European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
2020 · Leukemia · 1,470 citations
https://doi.org/10.1038/s41375-020-0776-2
D
Delphine Réa
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
415
Papers
19.8K
Citations
60
h-index
193
i10-index
Delphine Réa is an academic researcher from Saint Louis University Hospital. The author has contributed to research in topics: Chronic Myeloid Leukemia Treatments & Chronic Lymphocytic Leukemia Research & Eosinophilic Disorders and Syndromes. The author has an h-index of 60, co-authored 353 publications.
ORCID: 0000-0001-5379-7461Papers by this author
worksSETBP1 induces transcription of a network of development genes by acting as an epigenetic hub
2018 · Nature Communications · 152 citations
https://doi.org/10.1038/s41467-018-04462-8
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL
2023 · Leukemia · 126 citations
https://doi.org/10.1038/s41375-023-01829-9
Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results
2023 · Leukemia · 43 citations
https://doi.org/10.1038/s41375-023-01860-w
Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients
2021 · British Journal of Haematology · 42 citations
https://doi.org/10.1111/bjh.17654
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results
2024 · Leukemia · 42 citations
https://doi.org/10.1038/s41375-024-02278-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat